These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 24333909)
1. Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers. Liu L; Tang Y; Gao C; Li Y; Chen S; Xiong T; Li J; Du M; Gong Z; Chen H; Liu L; Yao P Colloids Surf B Biointerfaces; 2014 Mar; 115():125-31. PubMed ID: 24333909 [TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers. Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416 [TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carriers as a delivery system of biochanin A. Wang Q; Cheng H; Zhou K; Wang L; Dong S; Wang D; Chen W Drug Deliv; 2013 Nov; 20(8):331-7. PubMed ID: 24111887 [TBL] [Abstract][Full Text] [Related]
4. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Chen-yu G; Chun-fen Y; Qi-lu L; Qi T; Yan-wei X; Wei-na L; Guang-xi Z Int J Pharm; 2012 Jul; 430(1-2):292-8. PubMed ID: 22486962 [TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies. Jia L; Zhang D; Li Z; Duan C; Wang Y; Feng F; Wang F; Liu Y; Zhang Q Colloids Surf B Biointerfaces; 2010 Oct; 80(2):213-8. PubMed ID: 20621458 [TBL] [Abstract][Full Text] [Related]
6. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride. Ranpise NS; Korabu SS; Ghodake VN Colloids Surf B Biointerfaces; 2014 Apr; 116():81-7. PubMed ID: 24445002 [TBL] [Abstract][Full Text] [Related]
7. Lipid colloidal carriers for improvement of anticancer activity of orally delivered quercetin: formulation, characterization and establishing in vitro-in vivo advantage. Jain AS; Shah SM; Nagarsenker MS; Nikam Y; Gude RP; Steiniger F; Thamm J; Fahr A J Biomed Nanotechnol; 2013 Jul; 9(7):1230-40. PubMed ID: 23909137 [TBL] [Abstract][Full Text] [Related]
8. Design of Quercetin-Loaded Natural Oil-Based Nanostructured Lipid Carriers for the Treatment of Bacterial Skin Infections. de Barros DPC; Santos R; Reed P; Fonseca LP; Oliva A Molecules; 2022 Dec; 27(24):. PubMed ID: 36557947 [TBL] [Abstract][Full Text] [Related]
9. In vivo studies on the oridonin-loaded nanostructured lipid carriers. Zheng D; Dai W; Zhang D; Duan C; Jia L; Liu Y; Zhang Q Drug Deliv; 2012 Aug; 19(6):286-91. PubMed ID: 22928767 [TBL] [Abstract][Full Text] [Related]
10. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation. Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497 [TBL] [Abstract][Full Text] [Related]
11. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system. Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167 [TBL] [Abstract][Full Text] [Related]
12. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug. Hsu SH; Wen CJ; Al-Suwayeh SA; Chang HW; Yen TC; Fang JY Nanotechnology; 2010 Oct; 21(40):405101. PubMed ID: 20823498 [TBL] [Abstract][Full Text] [Related]
13. Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin. Shangguan M; Lu Y; Qi J; Han J; Tian Z; Xie Y; Hu F; Yuan H; Wu W J Biomater Appl; 2014 Feb; 28(6):887-96. PubMed ID: 24008629 [TBL] [Abstract][Full Text] [Related]
14. Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route. Gabal YM; Kamel AO; Sammour OA; Elshafeey AH Int J Pharm; 2014 Oct; 473(1-2):442-57. PubMed ID: 25062866 [TBL] [Abstract][Full Text] [Related]
15. Nose to Brain Delivery of Rivastigmine by In Situ Gelling Cationic Nanostructured Lipid Carriers: Enhanced Brain Distribution and Pharmacodynamics. Wavikar P; Pai R; Vavia P J Pharm Sci; 2017 Dec; 106(12):3613-3622. PubMed ID: 28923321 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. Li H; Zhao X; Ma Y; Zhai G; Li L; Lou H J Control Release; 2009 Feb; 133(3):238-44. PubMed ID: 18951932 [TBL] [Abstract][Full Text] [Related]
18. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine. Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388 [TBL] [Abstract][Full Text] [Related]
19. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery. Song X; Lin Q; Guo L; Fu Y; Han J; Ke H; Sun X; Gong T; Zhang Z Pharm Res; 2015 May; 32(5):1741-51. PubMed ID: 25407545 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]